Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$1,141.93	$83,491,746,043
	22,362,850	$1,141.93	$25,536,809,301
	17,233,668	$1,141.93	$19,679,642,500
	14,567,176	$1,141.93	$16,634,695,290
	9,033,726	$1,141.93	$10,315,882,732
	8,998,338	$1,141.93	$10,275,472,113
	8,322,140	$1,141.93	$9,503,301,331
	8,009,729	$1,141.93	$9,146,549,837
	7,619,135	$1,141.93	$8,700,518,831
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors Jan 4, 2023 08:00AM

Form SC 13D/A BELLUS Health Inc. Filed by: ORBIMED ADVISORS LLC Sep 3, 2021 04:37PM

Form SC 13D/A BELLUS Health Inc. Filed by: ORBIMED ADVISORS LLC Oct 23, 2020 06:02AM

Form SC 13D/A BELLUS Health Inc. Filed by: ORBIMED ADVISORS LLC Jun 11, 2020 04:26PM

Form SC 13D BELLUS Health Inc. Filed by: ORBIMED ADVISORS LLC Sep 18, 2019 04:17PM

Sep 9, 2019 09:09AM BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed